Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hyperuricemia Inversely Correlates with Disease Severity in Taiwanese Nonalcoholic Steatohepatitis Patients
Jee‐Fu Huang, Ming‐Lun Yeh, Ming‐Lung Yu, et al.
PLoS ONE (2015) Vol. 10, Iss. 10, pp. e0139796-e0139796
Open Access | Times Cited: 24

Showing 24 citing articles:

Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
Qing Ye, Biyao Zou, Yee Hui Yeo, et al.
˜The œLancet. Gastroenterology & hepatology (2020) Vol. 5, Iss. 8, pp. 739-752
Closed Access | Times Cited: 695
Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis
Ansel Shao Pin Tang, Cheng Han Ng, Poh Hui Phang, et al.
Clinical Gastroenterology and Hepatology (2022) Vol. 21, Iss. 7, pp. 1750-1760.e12
Closed Access | Times Cited: 76
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis
Limin Cao, Yu An, Huiyuan Liu, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 23
First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients
Jee‐Fu Huang, Chia‐Yen Dai, Chung‐Feng Huang, et al.
Hepatology International (2021) Vol. 15, Iss. 5, pp. 1136-1147
Open Access | Times Cited: 42
Relationship between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients
Alihan Oral, Tolga Şahin, Fatih Türker, et al.
Medicina (2019) Vol. 55, Iss. 9, pp. 600-600
Open Access | Times Cited: 49
Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis
Jee‐Fu Huang, Pei‐Chien Tsai, Ming‐Lun Yeh, et al.
Journal of the Formosan Medical Association (2019) Vol. 119, Iss. 1, pp. 89-96
Open Access | Times Cited: 47
Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis
Veeravich Jaruvongvanich, Wasin Ahuja, Kamonkiat Wirunsawanya, et al.
European Journal of Gastroenterology & Hepatology (2017) Vol. 29, Iss. 9, pp. 1031-1035
Closed Access | Times Cited: 40
Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study
Hsu‐Heng Yen, Pei–Yuan Su, Siou‐Ping Huang, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0252286-e0252286
Open Access | Times Cited: 29
Hyperuricemia Is Associated with Significant Liver Fibrosis in Subjects with Nonalcoholic Fatty Liver Disease, but Not in Subjects without It
Pei-Chia Yen, Yu-Tsung Chou, Chung‐Hao Li, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 5, pp. 1445-1445
Open Access | Times Cited: 17
Deletion of Smad4 reduces hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis progression
Geng Qin, Guo Zhen Wang, Dan Guo, et al.
Journal of Digestive Diseases (2018) Vol. 19, Iss. 5, pp. 301-313
Closed Access | Times Cited: 25
Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Nonobese Postmenopausal Women: A Cross-sectional Study
Ting Bao, Zhiye Ying, L. Gong, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 22
Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease
Mimi Zhou, Nan Yang, Xin Xing, et al.
BMC Gastroenterology (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients
Jee‐Fu Huang, Ming‐Lun Yeh, Chung‐Feng Huang, et al.
PLoS ONE (2017) Vol. 12, Iss. 5, pp. e0174394-e0174394
Open Access | Times Cited: 17
Association of hyperuricemia with disease severity in chronic hepatitis C patients
Tyng‐Yuan Jang, Ming‐Lun Yeh, Ching‐I Huang, et al.
PLoS ONE (2018) Vol. 13, Iss. 11, pp. e0207043-e0207043
Open Access | Times Cited: 17
Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis
Veeravich Jaruvongvanich, Wasin Ahuja, Karn Wijarnpreecha, et al.
European Journal of Gastroenterology & Hepatology (2017) Vol. 29, Iss. 6, pp. 694-697
Closed Access | Times Cited: 14
The efficacy of multi‐disciplinary lifestyle modifications in Taiwanese nonalcoholic steatohepatitis patients
Ming‐Lun Yeh, Chia‐Yen Dai, Chung‐Feng Huang, et al.
The Kaohsiung Journal of Medical Sciences (2024) Vol. 40, Iss. 6, pp. 575-582
Open Access | Times Cited: 1
Disease progression of nonalcoholic steatohepatitis in Taiwanese patients: a longitudinal study of paired liver biopsies
T. H. Lin, Ming‐Lun Yeh, Chung‐Feng Huang, et al.
European Journal of Gastroenterology & Hepatology (2018) Vol. 31, Iss. 2, pp. 224-229
Closed Access | Times Cited: 8
Improvement of hyperuricemia in chronic hepatitis C patients receiving directly acting antiviral agents
Tyng‐Yuan Jang, Ching‐I Huang, Ming‐Lun Yeh, et al.
Journal of Gastroenterology and Hepatology (2019) Vol. 35, Iss. 3, pp. 473-481
Closed Access | Times Cited: 8
The Burden of Nonalcoholic Steatohepatitis: A Systematic Review of Epidemiology Studies
Elliot B. Tapper, Charlotte Fleming, Adriana Rendón, et al.
Gastro Hep Advances (2022) Vol. 1, Iss. 6, pp. 1049-1087
Open Access | Times Cited: 3
First-In-Asian Double-Blind Randomized Trial To Assess The Efficacy And Safety Of Insulin Sensitizer In Nonalcoholic Steatohepatitis Patients
Jee‐Fu Huang, Chia‐Yen Dai, Chung‐Feng Huang, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 2
Clinical and Metabolic Characteristics of Hyperuricemia with Risk of Liver Fibrosis: A Cross-Sectional Study
Chunyi Wang, Hsiang-Han Kao, Kuan-Yu Lai, et al.
Metabolites (2022) Vol. 12, Iss. 10, pp. 893-893
Open Access | Times Cited: 1
Improvement in hepatic fibrosis estimated by Fibrosis-4 index in pegloticase treated chronic refractory gout patients
Naomi Schlesinger, Vinod K. Rustgi, Anthony E. T. Yeo, et al.
Clinical and Experimental Rheumatology (2021)
Open Access | Times Cited: 1
Outcomes of gout in patients with cirrhosis: A national inpatient sample-based study
Ayham Khrais, Aaron Kahlam, Tahir Ali, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 2, pp. 303-310
Open Access
Relationship Between Serum Uric Acid Levels and Non-alcoholic Fatty Liver Disease in the Non-Obese Chinese Population: A Secondary Analysis Based on A Cross-Sectional Study
Shengqiang Gao, Kuvaneshan Ramen, Shian Yu, et al.
Research Square (Research Square) (2021)
Closed Access
Page 1

Scroll to top